Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - KERYX BIOPHARMACEUTICALS INCkerx-12312017x10kex322.htm
EX-32.1 - EXHIBIT 32.1 - KERYX BIOPHARMACEUTICALS INCkerx-12312017x10kex321.htm
EX-31.2 - EXHIBIT 31.2 - KERYX BIOPHARMACEUTICALS INCkerx-12312017x10kex312.htm
EX-31.1 - EXHIBIT 31.1 - KERYX BIOPHARMACEUTICALS INCkerx-12312017x10kex311.htm
EX-23.1 - EXHIBIT 23.1 - KERYX BIOPHARMACEUTICALS INCkerx-12312017x10kex231.htm
EX-10.14 - EXHIBIT 10.14 - KERYX BIOPHARMACEUTICALS INCkerx-12312017x10kex1014.htm
EX-10.13 - EXHIBIT 10.13 - KERYX BIOPHARMACEUTICALS INCkerx12312017-10kex1013.htm
EX-10.12 - EXHIBIT 10.12 - KERYX BIOPHARMACEUTICALS INCkerx12312017-10kex1012.htm
10-K - 10-K - KERYX BIOPHARMACEUTICALS INCkerx-12312017x10k.htm
Exhibit 21.1
Keryx Biopharmaceuticals, Inc.
List of Subsidiaries

Name of Subsidiary
State/Jurisdiction of Incorporation
ACCESS Oncology, Inc.
Delaware
Accumin Diagnostics, Inc.
Delaware
AOI Pharma, Inc.
Delaware
AOI Pharmaceuticals, Inc.
Delaware
Neryx Biopharmaceuticals, Inc.
Delaware
Online Collaborative Oncology Group, Inc.
Delaware
Keryx Biomedical Technologies Ltd.
Israel
Keryx (Israel) Ltd.
Israel
Keryx Biopharma UK Ltd.
United Kingdom